GREP1 and non-small cell lung carcinoma: Our findings confirmed that LINC00514 is a new oncogene in NSCLC, highlighting that LINC00514 promotes EMT and regulates carcinogenic functions in NSCLC by positively regulating Wnt/β-catenin signaling.